Gemcitabine: all 1,576 studies that test it
Page 12 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast CancerCompletedNCT00813956Phase 2
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
- Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination ChemotherapyStatus unknownNCT00807261Phase 2
- Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
- Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00788099Phase 1
- Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic CancerTerminatedNCT00783172Phase 1
- Combined Biological Treatment and Chemotherapy for Patients With Inoperable CholangiocarcinomaCompletedNCT00779454Phase 2
- Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal CancerCompletedNCT00759226Phase 2
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II StudyCompletedNCT00747097Phase 2
- Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic CarcinomaCompletedNCT00744640Phase 1/2
- Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung CancerCompletedNCT00737867Phase 3
- First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerCompletedNCT00733850Phase 2
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- Gemcitabine/Oxaliplatin and Photodynamic Therapy in CholangiocarcinomaWithdrawnNCT00713687Phase 2
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00703365Phase 2
- Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00697905Phase 2
- Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder CancerCompletedNCT00696579Phase 1/2
- Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell CancerWithdrawnNCT00696007Phase 2
- The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
- Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerStatus unknownNCT00690872Phase 2
- A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid TumorsCompletedNCT00678977Phase 1
- AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor CancersCompletedNCT00678132Phase 1
- First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic CancerCompletedNCT00673504Phase 2
- Study of GemOx and Vandetanib in Advanced Solid MalignancyCompletedNCT00660725Phase 1
- Study Of Advanced Gastrointestinal Malignancies And Other Solid TumorsCompletedNCT00660426Phase 1
- Chemotherapy and Radiation Following Pancreatic SurgeryCompletedNCT00660270Phase 2
- Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin LymphomaCompletedNCT00660231Phase 2
- Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder CancerCompletedNCT00660140Phase 2
- Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCLCompletedNCT00655837Phase 1
- Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)CompletedNCT00655785Phase 1/2
- A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive MalignanciesTerminatedNCT00649584Phase 1
- A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00642733Phase 4
- Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic CancerTerminatedNCT00636883Phase 2
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00634725Phase 3
- Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersCompletedNCT00626158Phase 1
- Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell CarcinomaStatus unknownNCT00625352Phase 2
- Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct CancerSuspendedNCT00624182Phase 1
- Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerCompletedNCT00623064Phase 1
- Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic CancerCompletedNCT00622622Phase 1
- Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
- Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLCCompletedNCT00620971Phase 2
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung CancerTerminatedNCT00619021Phase 1
- A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid TumorsCompletedNCT00615446Phase 1
- Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the UterusCompletedNCT00614835Not applicable
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBCCompletedNCT00601159Phase 2
- A Phase I/Expansion Study of DasatinibTerminatedNCT00598091Phase 1
- Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNCT00593008Phase 1
- Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before SurgeryStatus unknownNCT00563160Phase 2
- Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast CancerCompletedNCT00561119Phase 3
- Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder CancerCompletedNCT00556621Phase 1/2
- A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaStatus unknownNCT00551252Phase 2
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownNCT00551122Phase 1/2
- Gemcitabine/Capecitabine/ZD6474 in Advanced Solid TumorsCompletedNCT00551096Phase 1
- LBH589 and Gemcitabine in the Treatment of Solid TumorsTerminatedNCT00550199Phase 1
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CancerCompletedNCT00547144Phase 1
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
- Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00541021Phase 3
- A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerSuspendedNCT00536770Phase 2
- Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2
- Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast CancerCompletedNCT00532623Phase 2
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
- Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCompletedNCT00515866Phase 1
- GEM vs GEM+TS-1 for Advanced Pancreatic CancerCompletedNCT00514163Phase 2
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract CancerCompletedNCT00504192Phase 2
- Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer PatientsCompletedNCT00500422Phase 1
- Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic CancerCompletedNCT00498225Phase 3
- Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanStatus unknownNCT00496704Phase 1/2
- Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCCCompletedNCT00496301Phase 2
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00491127Phase 2
- Intravesical Chemotherapy Treatment of Superficial Bladder CancerCompletedNCT00491114Phase 2
- Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder CancerCompletedNCT00490880Phase 2
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCompletedNCT00490659Phase 2
- Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCompletedNCT00490399Phase 2
- Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
- Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCompletedNCT00489983Phase 2
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerStatus unknownNCT00486460Phase 3
- Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00483366Phase 1
- Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerCompletedNCT00480597Phase 2
- A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
- Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid TumorsCompletedNCT00479128Phase 1
- A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced MalignanciesTerminatedNCT00475917Phase 1
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00470249Phase 2
- Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
- PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas CaCompletedNCT00467116Phase 1
- Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00462852Phase 2
- Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
- Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2